Antioxidant Effects of Salidroside in the Cardiovascular System.
Siyu SunQinhui TuoDongxu LiXiulong WangXuefang LiYiyue ZhangGuo-An ZhaoFei LinPublished in: Evidence-based complementary and alternative medicine : eCAM (2020)
Cardiovascular disease is one of the main human health risks, and the incidence is increasing. Salidroside is an important bioactive component of Rhodiola rosea L., which is used to treat Alzheimer's disease, tumor, depression, and other diseases. Recent studies have shown that salidroside has therapeutic effects, to some degree, in cardiovascular diseases via an antioxidative mechanism. However, evidence-based clinical data supporting the effectiveness of salidroside in the treatment of cardiovascular diseases are limited. In this review, we discuss the effects of salidroside on cardiovascular risk factors and cardiovascular diseases and highlight potential antioxidant therapeutic strategies.
Keyphrases
- cardiovascular disease
- cardiovascular risk factors
- anti inflammatory
- cardiovascular events
- oxidative stress
- endothelial cells
- metabolic syndrome
- randomized controlled trial
- cognitive decline
- systematic review
- risk factors
- depressive symptoms
- big data
- coronary artery disease
- electronic health record
- induced pluripotent stem cells
- machine learning
- artificial intelligence
- mild cognitive impairment